Newsroom

MD Anderson and Federation Bio Announce Collaboration to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers

February 1, 2023

Federation Bio Administers First Dose in Phase 1 Clinical Trial Evaluating Investigational Bacterial Cell Therapy

December 8, 2022

Federation Bio Expands Leadership Team To Support Continued Advancement of Engineered Bacterial Cell Therapies

November 30, 2022

Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies

October 6, 2020